{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:39:34Z","timestamp":1790872774865,"version":"4.1.0"},"reference-count":88,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Suicide is one of the leading causes of death worldwide and rates within the United States have risen over the past two decades. Hence, there is a critical need for novel tools to treat suicidal ideation and related mental health conditions. 3,4-Methylenedioxymethamphetamine (MDMA)\/ecstasy and classic psychedelics may be two such tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of this study was to assess non-causal associations between MDMA\/ecstasy and classic psychedelic use and psychological distress and suicide risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, we examined the aforementioned associations among 484,732 adult participants in the National Survey on Drug Use and Health (2008\u20132019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Lifetime MDMA\/ecstasy use was associated with reduced odds of past year suicidal thinking (10% reduced odds; odds ratio (OR)\u2009=\u20090.90; 95% confidence interval, CI\u2009=\u2009(0.84\u20130.97); p\u2009&lt;\u20090.01) and past year suicidal planning (OR\u2009=\u20090.88; 95% CI\u2009=\u2009(0.78\u20130.99); p\u2009&lt;\u20090.05). Furthermore, lifetime psilocybin use was associated with reduced odds of past month psychological distress (OR\u2009=\u20090.78; 95% CI\u2009=\u2009(0.73\u20130.84); p\u2009&lt;\u20090.001) and past year suicidal thinking (OR\u2009=\u20090.90; 95% CI\u2009=\u2009(0.83\u20130.96); p\u2009&lt;\u20090.01). Finally, lysergic acid diethylamide (LSD) was associated with increased odds of past year suicidal thinking (OR\u2009=\u20091.07; 95% CI\u2009=\u2009(1.00\u20131.15); p\u2009&lt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MDMA\/ecstasy and psilocybin use are associated with reduced odds of suicidal thinking and related outcomes\u2014though experimental studies are needed to determine whether these associations are causal. These findings call for more research into the efficacy of MDMA\/ecstasy and classic psychedelics for treating psychological distress and suicidal thoughts and behaviors, and for updated drug legislation that allows for further investigation into these substances.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811211058923","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T04:21:28Z","timestamp":1641356488000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":60,"title":["MDMA\/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-310X","authenticated-orcid":false,"given":"Grant M","family":"Jones","sequence":"first","affiliation":[{"name":"Department of Psychology, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K","family":"Nock","sequence":"additional","affiliation":[{"name":"Department of Psychology, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"bibr1-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119897615"},{"key":"bibr2-02698811211058923","volume-title":"Diagnostic and Statistical Manual of Mental Disorders : DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"bibr3-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/2045125314527985"},{"key":"bibr4-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2015.11.008"},{"key":"bibr5-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2015.03.002"},{"key":"bibr6-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"bibr7-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1111\/add.13774"},{"key":"bibr8-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1080\/09595230601036945"},{"key":"bibr9-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00222.x"},{"key":"bibr10-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2008.12.004"},{"key":"bibr11-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5010-9"},{"key":"bibr12-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(199705\/06)12:3<221::AID-HUP854>3.0.CO;2-C"},{"key":"bibr13-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2389"},{"key":"bibr14-02698811211058923","doi-asserted-by":"publisher","DOI":"10.3109\/07853890903485730"},{"key":"bibr15-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.8.804"},{"key":"bibr16-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.141358"},{"key":"bibr17-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.129056"},{"key":"bibr18-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1481827"},{"key":"bibr19-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000113"},{"key":"bibr20-02698811211058923","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-10-200405180-00015"},{"key":"bibr21-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-017-9831-9"},{"key":"bibr22-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1986.10472364"},{"key":"bibr23-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1998.10399713"},{"key":"bibr24-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"bibr25-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0457-5"},{"key":"bibr26-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"bibr27-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.3.205"},{"issue":"330","key":"bibr28-02698811211058923","first-page":"1","author":"Hedegaard H","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"330","key":"bibr29-02698811211058923","first-page":"1","author":"Hedegaard H","year":"2018","journal-title":"NCHS Data Brief"},{"key":"bibr30-02698811211058923","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:101761"},{"key":"bibr31-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117735685"},{"key":"bibr32-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115598338"},{"key":"bibr33-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565653"},{"key":"bibr34-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800503"},{"key":"bibr35-02698811211058923","volume-title":"Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits of MDMA","author":"Holland J","year":"2001"},{"key":"bibr36-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1093\/scan\/nst161"},{"key":"bibr37-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.12.048"},{"key":"bibr38-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0542-y"},{"key":"bibr39-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114548296"},{"key":"bibr40-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1308\/003588413X13511609956372"},{"key":"bibr41-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2015.08.016"},{"key":"bibr42-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031912-114409"},{"key":"bibr43-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.20.2487"},{"key":"bibr44-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1186\/s40479-020-00123-9"},{"key":"bibr45-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063972"},{"key":"bibr46-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000648"},{"key":"bibr47-02698811211058923","unstructured":"Lumley T (2020) Survey: Analysis of complex survey samples. R package version 4.0. Available at: https:\/\/CRAN.R-project.org\/package=survey (accessed 24 September 2020)."},{"key":"bibr48-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022"},{"key":"bibr49-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316676092"},{"key":"bibr50-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"bibr51-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05249-5"},{"key":"bibr52-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378371"},{"key":"bibr53-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112456611"},{"key":"bibr54-02698811211058923","first-page":"497","volume-title":"Frontiers in Psychiatry","volume":"11","author":"M\u00fcller F","year":"2020"},{"key":"bibr55-02698811211058923","unstructured":"Multidisciplinary Association for Psychedelic Studies (2020) A randomized, double-blind, placebo-controlled phase 2 pilot study of MDMA-assisted psychotherapy for anxiety associated with a life-threatening illness. NCT number: NCT02427568. ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02427568 (accessed 23 September 2020)."},{"key":"bibr56-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1002\/da.20674"},{"key":"bibr57-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2003.11.002"},{"key":"bibr58-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"bibr59-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3530"},{"key":"bibr60-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112464827"},{"key":"bibr61-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118806297"},{"key":"bibr62-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001356"},{"key":"bibr63-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117691453"},{"key":"bibr64-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117715596"},{"key":"bibr65-02698811211058923","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00138"},{"key":"bibr66-02698811211058923","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00896"},{"key":"bibr67-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1177\/0145445507304728"},{"key":"bibr68-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2005.08.005"},{"key":"bibr69-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.02.032"},{"key":"bibr70-02698811211058923","unstructured":"United States Department of Health Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2008) National survey on drug use and health, 2008. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr71-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2009) National survey on drug use and health, 2009. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr72-02698811211058923","unstructured":"United States Department of Health and Human United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2010) National survey on drug use and health, 2010. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr73-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2011) National survey on drug use and health, 2011. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr74-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2012) National survey on drug use and health, 2012. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr75-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2013) National survey on drug use and health, 2013. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr76-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2014) National survey on drug use and health, 2014. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr77-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2015) National survey on drug use and health, 2015. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr78-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2016) National survey on drug use and health, 2016. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr79-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2017) National survey on drug use and health, 2017. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr80-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2018) National survey on drug use and health, 2018. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr81-02698811211058923","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2019) National survey on drug use and health, 2019. Available at: https:\/\/datafiles.samhsa.gov\/"},{"key":"bibr82-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(03)00141-3"},{"key":"bibr83-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02065.x"},{"key":"bibr84-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2884"},{"key":"bibr85-02698811211058923","first-page":"S11","volume":"76","author":"Wilcox HC","year":"2004","journal-title":"Drug Abuse and Suicidal Behavior"},{"key":"bibr86-02698811211058923","unstructured":"World Health Organization (2019) Suicide. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/suicide (accessed 24 September 2020)."},{"key":"bibr87-02698811211058923","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.565"},{"key":"bibr88-02698811211058923","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01325"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811211058923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811211058923","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811211058923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:10:43Z","timestamp":1777507843000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811211058923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1177\/02698811211058923"],"URL":"https:\/\/doi.org\/10.1177\/02698811211058923","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}